Military Medical Research (Mar 2023)

Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research

  • Zhen-Hua Li,
  • Jun Wang,
  • Jing-Ping Xu,
  • Jian Wang,
  • Xiao Yang

DOI
https://doi.org/10.1186/s40779-023-00447-x
Journal volume & issue
Vol. 10, no. 1
pp. 1 – 20

Abstract

Read online

Abstract The rapid development of genome editing technology has brought major breakthroughs in the fields of life science and medicine. In recent years, the clustered regularly interspaced short palindromic repeats (CRISPR)-based genome editing toolbox has been greatly expanded, not only with emerging CRISPR-associated protein (Cas) nucleases, but also novel applications through combination with diverse effectors. Recently, transposon-associated programmable RNA-guided genome editing systems have been uncovered, adding myriads of potential new tools to the genome editing toolbox. CRISPR-based genome editing technology has also revolutionized cardiovascular research. Here we first summarize the advances involving newly identified Cas orthologs, engineered variants and novel genome editing systems, and then discuss the applications of the CRISPR-Cas systems in precise genome editing, such as base editing and prime editing. We also highlight recent progress in cardiovascular research using CRISPR-based genome editing technologies, including the generation of genetically modified in vitro and animal models of cardiovascular diseases (CVD) as well as the applications in treating different types of CVD. Finally, the current limitations and future prospects of genome editing technologies are discussed.

Keywords